MedTrace Logo

UltraShape Device Using the U-Sculpt/VDF Transducer for Flanks Fat

NCT02465762 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-04-14

No results posted yet for this study

Summary

Prospective, blinded, one arm, baseline-controlled clinical study for the evaluation of the UltraShape treatment for non-invasive fat and circumference reduction.

Study subjects will undergo UltraShape treatments on the flanks area using the U-Sculpt/VDF Transducer - 60 subjects.

Conditions

  • Unwanted Flanks Fat

Interventions

DEVICE

ultrashape Fat reduction

Ultrashape Device focused ultrasound to produce localized mechanical motion within fat tissues and cells for the purpose of producing mechanical cellular membrane disruption. It is intended for reduction in abdominal circumference.

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Principal Investigators

  • William P Coleman, MD · Coleman Center for Cosmetic Dermatologic Surgery 4425 Conlin Street, Metairie, Louisiana 70006

  • Michael Gold, MD · Gold Skin Care Center, 2000 Richard Jones Road, Suite 220, Nashville, TN 37215 USA

  • Robert Weiss, MD · 54 Scot Adams Road, Hunt Valley Baltimore USA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-07-31
Completion
2017-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02465762 on ClinicalTrials.gov